Side effects across medicines
Medicines whose labels list swelling of the legs
437 medicines have an FDA label that names swelling of the legs (peripheral edema) in its boxed warning, warnings, adverse reactions, trial table, patient leaflet or Drug Facts “stop use” warning (of the labels PlainMeds reads: each medicine's quoted label and up to eight more, by route and wording). Among them, the most FAERS reports of swelling of the legs name adalimumab (5,699), pregabalin (5,400) and methotrexate (5,142), through July 30, 2026. A label lists what its studies and reports found, and a report does not show that a medicine caused the event.
Check it at the source: the FDA FAERS public dashboard; FDA labels on DailyMed.
Which medicines' labels list swelling of the legs?
Ordered by where the label names it, the boxed warning first, then by FAERS reports. The first 151 of the 437 are below; every other one is on its medicine record. A medicine whose own indications name it, because it treats it, is not counted.
| Medicine | Where a label names it | FAERS reports of swelling of the legs |
|---|---|---|
| Nifedipine | precautions | 871 |
| Felodipine | precautions | 240 |
| Ketoconazole | precautions (oral label) | 170 |
| Amoxicillin and clarithromycin and lansoprazole | precautions | none in the top 1,000 |
| Rotigotine | warnings and precautions | none in the top 1,000 |
| Adalimumab | adverse reactions | 5,699 |
| Pregabalin | adverse reactions | 5,400 |
| Omeprazole | adverse reactions | 5,096 |
| Amlodipine | adverse reactions | 4,542 |
| Metoprolol | adverse reactions | 4,227 |
| Ambrisentan | adverse reactions | 4,197 |
| Gabapentin | adverse reactions | 4,085 |
| Lenalidomide | adverse reactions | 3,259 |
| Alendronate | adverse reactions | 2,920 |
| Sildenafil | adverse reactions | 2,736 |
| Quetiapine | adverse reactions | 2,419 |
| Carvedilol | adverse reactions | 2,418 |
| Celecoxib | adverse reactions | 2,336 |
| Alprazolam | adverse reactions | 2,291 |
| Tadalafil | adverse reactions | 2,244 |
| Rituximab | adverse reactions | 2,215 |
| Insulin glargine | adverse reactions | 2,113 |
| Oxycodone | adverse reactions | 2,054 |
| Tocilizumab | adverse reactions | 1,921 |
| Riociguat | adverse reactions | 1,790 |
| Tofacitinib | adverse reactions | 1,601 |
| Mycophenolate mofetil | adverse reactions | 1,600 |
| Certolizumab | adverse reactions | 1,319 |
| Morphine | adverse reactions | 1,152 |
| Risedronate | adverse reactions | 1,145 |
| Acyclovir | adverse reactions | 1,122 |
| Olanzapine | adverse reactions | 1,056 |
| Insulin lispro | adverse reactions | 1,043 |
| Sitagliptin | adverse reactions | 1,034 |
| Mirtazapine | adverse reactions | 1,023 |
| Bortezomib | adverse reactions | 1,022 |
| Pioglitazone | adverse reactions | 1,009 |
| Adalimumab-aaty | adverse reactions | 1,002 |
| Adalimumab-fkjp | adverse reactions | 1,000 |
| Denosumab | adverse reactions | 995 |
| Everolimus | adverse reactions | 973 |
| Bupropion | adverse reactions | 972 |
| Omalizumab | adverse reactions | 928 |
| Bevacizumab | adverse reactions | 926 |
| Tacrolimus | adverse reactions | 907 |
| Hydromorphone | adverse reactions | 879 |
| Enoxaparin | adverse reactions | 870 |
| Natalizumab | adverse reactions | 858 |
| Budesonide | adverse reactions (oral label) | 839 |
| Lamotrigine | adverse reactions | 812 |
| Letrozole | adverse reactions | 796 |
| Fentanyl | adverse reactions (transdermal label) | 794 |
| Risperidone | adverse reactions | 782 |
| Baclofen | adverse reactions (intrathecal label) | 759 |
| Pimavanserin | adverse reactions | 755 |
| Darbepoetin alfa | adverse reactions | 747 |
| Ibrutinib | adverse reactions | 736 |
| Gemcitabine | adverse reactions | 732 |
| Octreotide | adverse reactions (oral label) | 719 |
| Insulin aspart | adverse reactions | 695 |
| Estrogens conjugated | adverse reactions | 653 |
| Trastuzumab | adverse reactions | 652 |
| Docetaxel | adverse reactions | 642 |
| Pomalidomide | adverse reactions | 633 |
| Vancomycin | adverse reactions (oral label) | 605 |
| Imatinib | adverse reactions | 593 |
| Nivolumab | adverse reactions | 589 |
| Thalidomide | adverse reactions | 588 |
| Finasteride | adverse reactions | 585 |
| Insulin human | adverse reactions | 545 |
| Abiraterone | adverse reactions | 534 |
| Divalproex | adverse reactions | 526 |
| Enzalutamide | adverse reactions | 511 |
| Anastrozole | adverse reactions | 509 |
| Leuprolide | adverse reactions | 506 |
| Nebivolol | adverse reactions | 502 |
| Aprepitant | adverse reactions | 500 |
| Oxaliplatin | adverse reactions | 498 |
| Buprenorphine | adverse reactions (transdermal label) | 469 |
| Rabeprazole | adverse reactions | 459 |
| Varenicline | adverse reactions | 451 |
| Sunitinib | adverse reactions | 448 |
| Crizotinib | adverse reactions | 445 |
| Eculizumab | adverse reactions | 417 |
| Moxifloxacin | adverse reactions (intravenous label) | 411 |
| Indapamide | adverse reactions | 403 |
| Ribociclib | adverse reactions | 399 |
| Carbidopa and levodopa | adverse reactions (enteral label) | 392 |
| Fulvestrant | adverse reactions | 388 |
| Filgrastim | adverse reactions | 384 |
| Exemestane | adverse reactions | 377 |
| Amlodipine and valsartan | adverse reactions | 353 |
| Mycophenolic acid | adverse reactions | 343 |
| Pramipexole | adverse reactions | 335 |
| Telmisartan | adverse reactions | 313 |
| Raloxifene | adverse reactions | 312 |
| Nilotinib | adverse reactions | 298 |
| Prochlorperazine | adverse reactions | 287 |
| Buprenorphine and naloxone | adverse reactions | 285 |
| Paroxetine | adverse reactions | 285 |
| Pertuzumab | adverse reactions | 257 |
| Lenvatinib | adverse reactions | 256 |
| Lorlatinib | adverse reactions | 253 |
| Aliskiren | adverse reactions | 249 |
| Ixazomib | adverse reactions | 249 |
| Iron sucrose | adverse reactions | 248 |
| Voriconazole | adverse reactions | 247 |
| Capmatinib | adverse reactions | 245 |
| Azacitidine | adverse reactions | 236 |
| Hydrocodone | adverse reactions | 229 |
| Ropinirole | adverse reactions | 219 |
| Testosterone | adverse reactions (subcutaneous label) | 218 |
| Trametinib | adverse reactions | 216 |
| Carfilzomib | adverse reactions | 214 |
| Rifaximin | adverse reactions | 214 |
| Ipilimumab | adverse reactions | 213 |
| Sodium oxybate | adverse reactions | 213 |
| Teduglutide | adverse reactions | 213 |
| Bicalutamide | adverse reactions | 208 |
| Melphalan | adverse reactions | 208 |
| Upadacitinib | adverse reactions | 206 |
| Valganciclovir | adverse reactions | 206 |
| Insulin degludec | adverse reactions | 203 |
| Itraconazole | adverse reactions | 202 |
| Mifepristone | adverse reactions | 202 |
| Eszopiclone | adverse reactions | 199 |
| Niacin | adverse reactions | 188 |
| Ritonavir | adverse reactions | 185 |
| Amantadine | adverse reactions | 183 |
| Glatiramer | adverse reactions | 182 |
| Interferon beta 1b | adverse reactions | 182 |
| Pazopanib | adverse reactions | 182 |
| Dabrafenib | adverse reactions | 180 |
| Tolterodine | adverse reactions | 180 |
| Valproic acid | adverse reactions | 178 |
| Metformin and sitagliptin | adverse reactions | 175 |
| Alendronate and cholecalciferol | adverse reactions | 170 |
| Meropenem | adverse reactions | 166 |
| Paricalcitol | adverse reactions | 159 |
| Somatropin | adverse reactions | 158 |
| Progesterone | adverse reactions (vaginal label) | 154 |
| Insulin glulisine | adverse reactions | 141 |
| Romiplostim | adverse reactions | 140 |
| Terazosin | adverse reactions | 140 |
| Lubiprostone | adverse reactions | 135 |
| Sodium ferric gluconate complex | adverse reactions | 135 |
| Hydrochlorothiazide and lisinopril | adverse reactions | 133 |
| Temozolomide | adverse reactions | 133 |
| Alemtuzumab | adverse reactions | 132 |
| Asenapine | adverse reactions | 131 |
| Methotrexate | patient leaflet | 5,142 |
Source: FDA drug labels via openFDA, read October 8, 2026; FAERS via openFDA, reports through July 30, 2026
Which of them have the most swelling of the legs reports in FAERS?
Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; MedDRA preferred term “Oedema Peripheral”
What next?
- Side effects across medicines
- every reaction on PlainMeds
- Report a side effect to the FDA
- MedWatch